Virios Therapeutics, Inc. Q2 2023 Earnings Call Transcript
VIRIDelisted Stock | USD 3.95 0.00 0.00% |
Under 55% of Virios Therapeutics' investor base is interested to short. The analysis of current outlook of investing in Virios Therapeutics Llc suggests that many traders are impartial regarding Virios Therapeutics' prospects. Virios Therapeutics' investing sentiment shows overall attitude of investors towards Virios Therapeutics Llc.
Virios |
Virios Therapeutics, Inc. Q2 2023 Earnings Call Transcript August 10, 2023 Virios Therapeutics, Inc. misses on earnings expectations. Reported EPS is -0.08 EPS, expectations were -0.07. Operator Good day, and welcome to the Virios Therapeutics, Inc. Q2 2023 Earnings Update. At this time, all participants have been placed in a listen-only mode. Please be
Read at finance.yahoo.com
Virios Therapeutics Fundamental Analysis
We analyze Virios Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virios Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virios Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Virios Therapeutics is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Virios Therapeutics Llc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Virios Therapeutics stock to make a market-neutral strategy. Peer analysis of Virios Therapeutics could also be used in its relative valuation, which is a method of valuing Virios Therapeutics by comparing valuation metrics with similar companies.
Peers
Virios Therapeutics Related Equities
CYTO | Altamira Therapeutics | 7.50 | ||||
IMMX | Immix Biopharma | 7.11 | ||||
PHIO | Phio Pharmaceuticals | 3.03 | ||||
RNAZ | Transcode Therapeutics | 2.94 | ||||
ZURA | Zura Bio | 1.67 | ||||
REVB | Revelation Biosciences | 1.33 | ||||
ICU | LMF Acquisition | 1.57 | ||||
SONN | Sonnet Biotherapeutics | 2.28 | ||||
ZVSA | ZyVersa Therapeutics | 3.60 | ||||
CNSP | Cns Pharmaceuticals | 8.33 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Virios Stock
If you are still planning to invest in Virios Therapeutics Llc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Virios Therapeutics' history and understand the potential risks before investing.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |